Undifferentiated Spondyloarthropathies in Brazilians: Importance of HLA-B27 and the B7-CREG Alleles in Characterization and Disease Progression

Journal of Rheumatology

Volumn 30, Issue 12, 2003, Pages 2632-2637

  Sampaio Barros, Percival D ^a,b   Conde, Roseneide A ^a,b   Donadi, Eduardo A ^a,c   Kraemer, Maria Helena S ^a,d   Persoli, Ligia ^a,e   Coimbra, Ibsen B ^a,f   Costallat, Lilian Teresa L ^a,d   Samara, Adil M ^a,d,f   Bértolo, Manoel B ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b Laboratory of Rheumatology   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^d Department of Clinical Pathology ^*

^e Haematology Unit

^f Rheumatology Unit   (Brazil)

Author keywords

Alleles; Followup; HLA B27; Spondyloarthropathies; Undifferentiated spondyloarthropathies

Indexed keywords

HLA B27 ANTIGEN; HLA B7 ANTIGEN;

ADULT; ALLELE; ARTICLE; BRAZIL; CONTROLLED STUDY; CROSS REACTION; DISEASE COURSE; DNA HYBRIDIZATION; FEMALE; GENE FREQUENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPONDYLOARTHROPATHY;

ADOLESCENT; ALLELES; BRAZIL; CHILD; DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-B27 ANTIGEN; HLA-B7 ANTIGEN; HUMANS; INFANT; JOINTS; MALE; OUTPATIENTS; PROSPECTIVE STUDIES; SPONDYLITIS;

EID: 0346848790     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Calin A. Terminology, introduction, diagnostic criteria, and overview. In: Calin A, Taurog JD, editors. The spondylarthritides. Oxford: Oxford University Press; 1998:1-15.
2. Khan MA. Update on spondyloarthropathies. Ann Intern Med 2002;136:896-907.
3. Reveille JD, Ball EJ, Khan MA. HLA-B27 and genetic predisposing factors in spondyloarthropathies. Curr Opin Rheumatol 2001;13:265-72.
4. Nasution AR, Mardjuadi A, Kunmartini S, et al. HLA-B27 subtypes positively and negatively associated with spondyloarthropathy. J Rheumatol 1997;24:1111-4.
5. D'Amato M, Fiorillo MT, Carcassi C, et al. Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. Eur J Immunol 1995;25:3199-201.
6. Khan MA, Kushner I, Braun WE. A subgroup of ankylosing spondylitis associated with HLA-B7 in American blacks. Arthritis Rheum 1978;21:528-30.
7. Cedoz JP, Wendling D, Viel JF. The B7 cross reactive group and spondyloarthropathies: an epidemiological approach. J Rheumatol 1995;22:1884-90.
8. Robinson WP, Van der Linden SM, Khan MA, et al. HLA-Bw60 increases susceptibility to ankylosing spondylitis in HLA-B27 positive patients. Arthritis Rheum 1989;32:1135-41.
9. Arnett FC, Hochberg MC, Bias WB. Cross-reactive HLA antigens in B27-negative Reiter's syndrome and sacroiliitis. Johns Hopkins Med J 1977;141:193-7.
10. Ben-Chetrit E, Brautbar C, Rubinow A. HLA antigens in Reiter's syndrome in Israeli patients. J Rheumatol 1985;12:964-6.
11. Stein M, Davis P, Emmanuel J, West G. The spondyloarthropathies in Zimbabwe: A clinical and immunologic profile. J Rheumatol 1990;17:1337-9.
12. Zeidler H, Mau W, Khan MA. Undifferentiated spondyloarthropathies. Rheum Dis Clin North Am 1992;18:187-202.
13. Shattenkirchner M, Kruger K. Natural course and prognosis of HLA-B27 positive oligoarthritis. Clin Rheumatol 1987;6 Suppl 2:83-6.
14. Mau W, Zeidler H, Mau R, et al. Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year follow-up. J Rheumatol 1988;15:1109-14.
15. Burch VC, Isaacs S, Kalla AA. Ethnicity and patterns of spondyloarthritis in South Africa - Analysis of 100 patients. J Rheumatol 1999;26:2195-200.
16. Mijiyawa M, Oniankitan O, Khan MA. Spondyloarthropathies in sub-Saharan Africa. Curr Opin Rheumatol 2000;12:281-6.
17. Feldtkamp TE, Mardjuadi A, Huang F, Chou CT. Spondyloarthropathies in eastern Asia. Curr Opin Rheumatol 2001;13:285-90.
18. Kumar A, Bansal M, Srivastava DN, et al. Long-term outcome of undifferentiated spondyloarthropathy. Rheumatol Int 2001;20:221-4.
19. Erdesz S, Shubin SV, Shoch BP, et al. Spondyloarthropathies in circumpolar populations of Chukotka (Eskimos and Chukchi): epidemiology and clinical characteristics. J Rheumatol 1994;21:1101-4.
20. Boyer GS, Templin DW, Bowler A, et al. Spondyloarthropathy in the community: clinical syndromes and disease manifestations in Alaskan Eskimo populations. J Rheumatol 1999;26:1537-44.
21. Sampaio-Barros PD, Bertolo MB, Kraemer MHS, Marques-Neto JF, Samara AM. Undifferentiated spondyloarthropathies: a 2-year follow-up study. Clin Rheumatol 2001;20:201-6.
22. Dougados M, van der Linden S, Juhlin R, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-27.
23. Amor B, Dougados M, Mijiyawa M. Criteria of the classification of spondylarthropathies [French]. Rev Rhum 1990;57:85-9.
24. Calin A, Porta J, Fries J, Schurman DJ. Clinical history as a screening test for ankylosing spondylitis. JAMA 1977;237:2613-4.
25. Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
26. Louzada P Jr, Smith AG, Hansen JA, Donadi EA. HLA-DRB1 and -DQB1 alleles in the Brazilian population of the northeastern region of the State of São Paulo. Tissue Antigens 2001;57:158-62.
27. Collantes E, Veroz R, Escudero A, et al. Can some cases of "possible" spondyloarthropathy be classified as "definite" or "undifferentiated" spondyloarthropathy? Value of criteria for spondyloarthropathies. Joint Bone Spine 2000;67:516-20.
28. Amor B. Usefulness of criteria for spondyloarthropathies. Joint Bone Spine 2000;67:502-3.
29. Burgos-Vargas R, Pacheco-Tena C, Vásquez-Mellado J. Juvenile-onset spondyloarthropathies. Rheum Dis Clin North Am 1997;23:569-98.
30. Olivieri I, Salvarani C, Cantini F, Cianclo G, Padula A. Ankylosing spondylitis and undifferentiated spondyloarthropathies: a clinical review and description of a disease subset with older age at onset. Curr Opin Rheumatol 2001;13:280-4.
31. Alvarez I, López de Castro JA. HLA-B27 and immunogenetics of spondyloarthropathies. Curr Opin Rheumatol 2000;12:248-53.
32. Khan MA. A worldwide overview: the epidemiology of HLA-B27 and associated spondyloarthritides. In: Calin A, Taurog JD, editors, The spondylarthritides. Oxford: Oxford University Press; 1998:17-27.
33. Krylov M, Erdesz S, Alexeeva L, Benevolenskaya L, Arnett FC, Reveille JD. HLA class II and HLA-B27 oligotyping in two Siberian native population groups. Tissue Antigens 1995;46:382-6.
34. Brown MA, Jepson A, Young A, Whittle HC, Greenwood BM, Wordsworth BP. Ankylosing spondylitis in West Africans - evidence for a non-HLA-B27 protective effect. Ann Rheum Dis 1997;56:68-70.
35. Fraile A, Martin J, Lopez-Nevot MA, et al. HLA-B*27 subtyping by PCR-RFLP in Spanish patients with ankylosing spondylitis. Tissue Antigens 1998;52:492-6.
36. Lopez-Larrea C, Gonzalez S, Martinez-Eorra J. The role of HLA-B27 polymorphism and molecular mimicry in spondylarthropathy. Mol Med Today 1998;4:540-9.
37. Yamaguchi A, Ogawa A, Tsuchiya N, et al. HLA-B27 subtypes in Japanese with seronegative spondyloarthropathies and healthy controls. J Rheumatol 1996;23:1189-93.
38. Garcia-Fernandez, Gonzalez S, Mina Blanco A, et al. New insights regarding HLA-B27 diversity in the Asian population. Tissue Antigens 2001;58:259-62.
39. Armas JB, Gonzalez S, Martinez-Borra J, et al. Susceptibility to ankylosing spondylitis is independent of the Bw4 and Bw6 epitopes of HLA-B27 allele. Tissue Antigens 1999;53:237-43.
40. Gonzalez S, Garcia-Fernandez S, Martinez-Borra J, et al. High variability of HLA-B27 alleles in ankylosing spondylitis and related spondyloarthropathies in the population of Northern Spain. Hum Immunol 2002;63:673-6.
41. Sampaio-Barros PD, Bertolo MB, Kraemer MHS, Marques-Neto JF, Samara AM. Primary ankylosing spondylitis: patterns of disease in a Brazilian population of 147 patients. J Rheumatol 2001;28:560-5.
42. Martinez-Borra J, Gonzalez S, Lopez-Larrea C. Genetic factors predisposing to spondyloarthropathies. Arthritis Rheum 2000;44:2679-85.
43. Brown M, Crane A, Wordsworth BP. Genetic aspects of susceptibility, severity, and clinical expression in ankylosing spondylitis. Curr Opin Rheumatol 2002;14:354-60.
44. Sieper J, Rudwaleit M, Braun J, van der Heijde D. Diagnosing reactive arthritis: Role of clinical setting in the value of serologic and microbiologic assays. Arthritis Rheum 2002;46:319-27.
45. Fendler C, Laitko S, Sorensen H, et al. Frequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis. Ann Rheum Dis 2001;60:337-43.
46. Gerard HC, Wang Z, Wang GF, et al. Chromosomal DNA from a variety of bacterial species is present in synovial tissue from patients with various forms of arthritis. Arthritis Rheum 2001;44:1689-97.